A Aralex Aachen research explorer

Company ROR OpenAlex

Pharming Group (Netherlands) Sign in to save

45 stored papers · Search its papers → · Its authors →

Papers 45

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
2020 Frontiers in Immunology article Medicine COVID-19 Clinical Research Studies Open access cited by 3 patents

85

citations
Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation
2020 American Journal of Transplantation article Medicine Renal Transplantation Outcomes and Treatments Open access cited by 1 patent

31

citations
PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond
2023 The Journal of Allergy and Clinical Immunology In Practice article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

27

citations
Plasma-derived and recombinant C1 esterase inhibitor: Binding profiles and neuroprotective properties in brain ischemia/reperfusion injury
2021 Brain Behavior and Immunity article Immunology and Microbiology Complement system in diseases Open access

18

citations
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry
2021 World Allergy Organization Journal article Medicine Coagulation, Bradykinin, Polyphosphates, and Angioedema Open access cited by 2 patents

13

citations
Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus
2020 Mayo Clinic Proceedings Innovations Quality & Outcomes article Medicine Coagulation, Bradykinin, Polyphosphates, and Angioedema Open access

12

citations
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study
2024 Clinical & Experimental Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

7

citations
A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS)
2024 Orphanet Journal of Rare Diseases article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

7

citations
Clinical development and marketing application review times for novel orphan-designated drugs
2024 Frontiers in Medicine article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

6

citations
Efficient Synthesis of 1′,4′-Dihydro-2′H-spiro[indoline-3,3′-quinoline] Derivatives for the Identification of New Spirocyclic Herbicidal Leads
2025 Journal of Agricultural and Food Chemistry article Agricultural and Biological Sciences Weed Control and Herbicide Applications

4

citations
Natural history of clinical manifestations in activated phosphoinositide 3-kinase δ syndrome (APDS): Time-to-event analyses using the European Society for Immunodeficiencies-APDS registry
2025 Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

3

citations
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders
2024 Global & Regional Health Technology Assessment article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access

3

citations
Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)
2025 Global & Regional Health Technology Assessment article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access

2

citations
Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects
2025 Expert Review of Clinical Immunology article Biochemistry, Genetics and Molecular Biology PI3K/AKT/mTOR signaling in cancer Open access

1

citations
The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5D
2025 Advances in Therapy article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access

1

citations
Systematic literature reviews to identify epidemiological, clinical, economic and health-related quality of life evidence in activated PI3Kδ syndrome (APDS)
2025 BMC Immunology review Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

1

citations
Leniolisib reduced lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome
2025 Journal of Human Immunity article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

1

citations
Design, Synthesis, and Bioactivity of Novel Ethyl 2-Oxo-4-phenylbut-3-enoate Derivatives as Potential Herbicide Candidates
2026 Journal of Agricultural and Food Chemistry article Agricultural and Biological Sciences Weed Control and Herbicide Applications

1

citations
63 Clinical Roadmap for Implementing Results from Electronic Health Records Queries
2024 Clinical Immunology article Health Professions Electronic Health Records Systems

1

citations
HTA74 Clinical and Economic Factors Underlying QALY Weights and Severity Modifiers in NICE Health Technology Evaluations: An Analysis of Recent Appraisals
2025 Value in Health conference-abstract Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life

1

citations

Most cited authors